Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorUniversity of Malaya
About this trial
This observational study aims to understand why some adults with diabetes find it difficult to take their medicines as prescribed. Medication adherence is essential for controlling blood sugar levels and preventing complications, yet many patients face challenges that go beyond personal motivation.
The study will examine multiple factors that may influence medication-taking behavior, including patients' understanding of their medicines, beliefs about treatment, family and social support, communication with healthcare providers, and practical issues such as medicine cost, availability, and distance to care. These factors will be analyzed using a structured behavioral framework to better understand how capability, opportunity, and motivation contribute to adherence.
By identifying the most important barriers and supports across different levels, this research aims to provide evidence that can guide patient-centered care strategies and improve medication adherence in diabetes management.
Eligibility criteria
Qualifiers
Adults aged 18 years or older
Diagnosed with at least one chronic disease (e.g., diabetes mellitus, hypertension, cardiovascular disease, chronic respiratory disease, chronic kidney disease) for a minimum duration of six months
Prescribed long-term medication therapy
Able to understand and respond to the study questionnaire
Disqualifiers
Patients with acute medical conditions requiring immediate care
Individuals with severe cognitive impairment or psychiatric illness that would preclude reliable participation
Patients who are terminally ill
Patients unwilling to participate or provide consent
Trial design
Treatments tested in this trial
- Multilevel Ecological Determinants of Medication Adherence
Treatment groups
220 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Malaya
Lead sponsor
Maharishi Markendeswar University (Deemed to be University)
Collaborator
Source ClinicalTrials.gov